Allspring Global Investments Holdings LLC Acquires 59,343 Shares of Axon Enterprise, Inc $AXON

Allspring Global Investments Holdings LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 97.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 120,178 shares of the biotechnology company’s stock after buying an additional 59,343 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.15% of Axon Enterprise worth $67,714,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of AXON. Brighton Jones LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $480,000. NewEdge Advisors LLC lifted its holdings in shares of Axon Enterprise by 41.1% in the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC lifted its holdings in shares of Axon Enterprise by 8.4% in the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after purchasing an additional 157 shares in the last quarter. Woodline Partners LP boosted its position in shares of Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after buying an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in shares of Axon Enterprise during the second quarter worth about $284,000. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price on the stock in a research report on Tuesday, January 6th. Morgan Stanley reduced their price target on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. UBS Group decreased their price target on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th. Craig Hallum reissued a “buy” rating and issued a $820.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Citigroup restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $762.93.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total value of $5,002,400.00. Following the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at $1,546,240,339.28. This represents a 0.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Isaiah Fields sold 2,000 shares of the stock in a transaction on Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the transaction, the insider owned 55,588 shares in the company, valued at $29,740,135.88. The trade was a 3.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 23,855 shares of company stock valued at $13,299,928 in the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Up 2.3%

Shares of Axon Enterprise stock opened at $424.69 on Wednesday. The business has a fifty day simple moving average of $493.71 and a two-hundred day simple moving average of $585.07. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91. The company has a market capitalization of $34.15 billion, a price-to-earnings ratio of 279.40, a P/E/G ratio of 8.86 and a beta of 1.46. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.60 by $0.55. The firm had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The company’s quarterly revenue was up 38.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.08 earnings per share. Research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.